Featured Content
The McGovern Center was founded in 2008 as a startup incubator to help develop young Cornell life science companies. The Center is funded by Cornell’s Research Division, the Institute of Biotechnology, NYSTAR and a generous gift from Kevin M. McGovern ’70 and his family.
The Center’s program focuses on accelerating research and development of its client’s companies’ technology and products, validating its client companies’ business plans, and strengthening their management teams. The Center’s goal is to facilitate the forward progress of client companies to the point where each will merit significant outside investment, and achieve self-sufficiency. In doing so, the McGovern Center contributes to the University’s mission as New York State’s Morrill Land Grant institution to support local, regional, and state-wide Life Sciences jobs/economic development.
News
Two McGovern Center startups graduate from incubator
November 03, 2019
By Blaine Friedlander | October 21, 2019 With a pinch of pomp and circumstance, Cornell’s McGovern Center life sciences business incubator recently graduated two companies – Bactana Corp. and Conamix. “Entrepreneurship is a part of Cornell’s …
Rapid Lyme disease test may be available in late 2020
September 10, 2019
By Blaine Friedlander | September 4, 2019 The drawn-out process for diagnosing Lyme disease could become a thing of the past – good news for the thousands of people each year who get the tick-borne …
McGovern Center Graduate EMBARK digs up $10M bones to end preventable disease in dogs
August 03, 2019
Biotech startup raises Series A funding to build out the world’s largest database of canine DNA for genetic disease research Boston, MA (April 10, 2019)—Boston-based Embark Veterinary Inc., the world leader in dog genetics, announced …
McGovern Center Graduate Sterifre Medical Announces the Successful Completion of its Series B Financing
August 02, 2019
KIRKLAND, Wash., July 29, 2019 /PRNewswire/ — Sterifre Medical, Inc., today announced that it has officially raised $8 million in a Series B private equity round of financing. Sterifre had previously raised $12 million in a 2017 …